Page 3 - Ongoing Research Development News Today

/PRNewswire/ -- The "Global KRAS Inhibitors Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.coms offering. The advancement...

/PRNewswire/ -- The "Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026" report has been added to...

/PRNewswire/ -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.coms offering. The global Trop2...

/PRNewswire/ -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.coms offering. The global Trop2...

Share this article Share this article ResearchAndMarkets.coms offering. Over the past few years, the idea of immunotherapy of ability to manipulate immune cells in targeting tumor cells is gaining momentum in field of cancer therapeutics. Since then scientists have developed a wide range of potential candidates which has shown encouraging results in the management of cancer. The recent clinical success of chimeric antigen receptor in the management of hematological malignancies has clearly led ...

Share this article Share this article ResearchAndMarkets.coms offering. RET inhibitor therapy market is a novel, unique yet a challenging aspect followed by the oncology researchers for the treatment of different types of cancers. Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026 Report Highlights: Global RET Inhibitors Market Opportunity: > USD 1.5 Billion Global RET Inhibitors Market Absolute Growth : 3900% (2020-2026) RET inhibitors clinical Trials Insight by Com...

ResearchAndMarkets.com’s offering. RET inhibitor therapy market is a novel, unique yet a challenging aspect followed by the oncology researchers for the treatment of different types of cancers. Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026 Report Highlights: Global RET Inhibitors Market Opportunity: > USD 1.5 Billion Global RET Inhibitors Market Absolute Growth : 3900% (2020-2026) RET inhibitors clinical Trials Insight by Company, Country, Indication & Phase RET...

Global KRAS Inhibitors Drug Market Sales Size Opportunity Clinical Development To Surpass USD 1 Billion By 2025 NEW DELHI, Feb. 15, 2021 /PRNewswire/ -- "Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025" Report Highlights: KRAS Inhibitors Market Opportunity: > USD 1 Billion by 2025 Initially US To Dominate KRAS Inhibitors Market: >90% Market Share Number of KRAS Inhibitors In Trials: > 20 Drugs Highest Phase of Clinical Development: Phase-III Study Solid Tumors Targ...

Share this article Share this article ResearchAndMarkets.coms offering. The fast pace of cancer prevalence and mortality rate across the globe has led to an increasing concern as well as recognition that the specific disease requires attention by the researchers. In the past few years, the type of research activities that have been conducted for cancer disease has moved several laboratory findings to the commercial world. In one of the scenarios, development of cancer biological toxins is a fo...